Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
PT Cell Type	12.99B
PT Cell Type Growth	96.10%
Semi Gel Type	9.69B
Semi Gel Type Growth	-35.96%
Hydrocolloids	2.42B
Hydrocolloids Growth	142.42%
Other	3.32B
Other Growth	-27.39%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
South Korea	22.73B
South Korea Growth	13.89%
Asia	19.22B
Asia Growth	34.61%
America	73.22M
Consolidated Adjustment	-13.60B
Consolidated Adjustment Growth	96.89%